PL EN

EMA: European Medicines Agency updates product information template to label medicines subject to additional monitoring and encourage adverse-reaction reporting

21.03.2013
As part of the implementation of the European Union (EU) pharmacovigilance legislation, the European Medicines Agency has updated the product-information template to allow easy identification of human medicines that are subject to additional monitoring and to encourage adverse-reaction reporting for all medicines.

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny